GLIDEAZE Trademark

Trademark Overview


On Tuesday, November 9, 2021, a trademark application was filed for GLIDEAZE with the United States Patent and Trademark Office. The USPTO has given the GLIDEAZE trademark a serial number of 97115620. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, October 10, 2024. This trademark is owned by Pfizer Inc.. The GLIDEAZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Syringes sold filled with anti-arrhythmics, anesthetics, electrolyte solutions, imaging agents or diluents
glideaze

General Information


Serial Number97115620
Word MarkGLIDEAZE
Filing DateTuesday, November 9, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Syringes sold filled with anti-arrhythmics, anesthetics, electrolyte solutions, imaging agents or diluents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, November 12, 2021NEW APPLICATION ENTERED
Wednesday, November 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 8, 2022ASSIGNED TO EXAMINER
Tuesday, August 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 21, 2023ASSIGNED TO EXAMINER
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 5, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 5, 2023SOU EXTENSION 1 GRANTED
Wednesday, April 5, 2023SOU EXTENSION 1 FILED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 9, 2024SOU EXTENSION 3 FILED
Tuesday, April 9, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 12, 2023SOU EXTENSION 2 FILED
Thursday, October 12, 2023SOU EXTENSION 2 GRANTED
Saturday, October 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 9, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 10, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2024SOU EXTENSION 4 FILED
Thursday, October 10, 2024SOU EXTENSION 4 GRANTED